All good points, Pipedream. There is strong evidence that a lot of new eyes are on Scrips and its ever brighter prospects.The compounding market is showing huge strength and many people prefer it, including all those with allergies or troubles affecting the immune system. Maybe there's a fair comparison to be made with the strengths of 3D printing: which allows the customer (the originator) to make all the choices that matter, with better formulation reflecting personal preferences.Not forgetting: if Scrips can find its way into the Chinese market this year, that will be a game-changer, and it can't be excluded.

That's not a bad-looking chart, either!